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Background: Toxoplasmosis is one of the most common parasitic zoonoses. The seroprevalence of Toxoplasma
gondii infection in humans varies widely worldwide. Detection of Toxoplasma-specific antibodies has been a gold
standard method for both epidemiological investigation and clinical diagnosis. Genetic investigation indicated that
there is a wide distribution of different genome types or variants of the parasite prevalent in different areas. Thus
the reliability of using antigens from parasites of a single genome type for diagnosis and epidemiology purposes
needs to be extensively evaluated.
Methods: In this study, the prevalence of T. gondii infection among 880 clinically healthy individuals in China was
systematically tested using crude soluble native antigens and purified recombinant antigens of type I and II T. gondii.
The T. gondii-specific IgG and IgM in the sera was further confirmed using commercial Toxoplasmosis Diagnosis Kits
and Western blot assays.
Results: The sero-prevalence of T. gondii-specific IgG detected with crude native Type I and type II antigens was 12.2%
and 11.3% respectively. Whereas the overall prevalence was more than 20% when combined with the results obtained
with recombinant tachyzoite and bradyzoite antigens. There was an obvious variation in immune-recognition of
parasite antigens among the individuals studied.
Conclusions: The general prevalence of anti-T. gondii IgG in the study population was likely much higher than
previously reported. The data also suggested that there is more genetic diversity among the T. gondii isolates in China.
Further, combination of recombinant antigens with clear immuno-recognition will be able to generate more sensitive
diagnostic results than those obtained with crude antigens of T. gondii tachyzoites.
Keywords: Toxoplasma gondii, Prevalence, Antigens, ChinaBackground
Toxoplasma gondii is an intracellular parasite that can
infect domestic, wild, and companion animals, and it
also commonly infects humans [1]. The importance of
this parasite in food safety, human health and animal
husbandry has been well recognized. Though T. gondii
infection in humans with a normal immune competence
is asymptomatic in most cases, the parasites do pose
threats to individuals who are immunocompromised,* Correspondence: cqj@jlu.edu.cn; jiangning@jlu.edu.cn
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reproduction in any medium, provided the orsuch as HIV carriers [2]. It has been estimated that up to
one third of the world’s population has been infected by
T. gondii with an endemicity from around 10% to 70%
[1,3-5] and the prevalence is higher in warm and humid
areas [6-8]. In several studies, patients with schizophre-
nia were found to have a higher tendency of T. gondii in-
fection [9-12], but there has been no conclusive
correlation between T. gondii infection and psychiatric
disease [13].
Toxoplasma gondii displays significant genetic diver-
sity in different geographical regions [14-16]. Currently,
toxoplasmosis is diagnosed primarily by demonstrating. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.






Primer sequence (5’-3’) Amplified
product (bp)
SAG5D AY190528.1 F-GATGCGACCGGAACGACCC 981
R-ATATGTGCCAAGAAAGACA
SAG5A AF013968.3 F-GAGGTAACGAATGTTCTG 1002
R-GTATGCACCGAAAGAAACA
MIC6 AF110270.1 F-TCCCCGTTTTTTGCCTTTC 792
R-ATGTCCACTTCCTTCCTC
SRS4 XM_002366109.1 F-CCACATGAAGGTAGTTTG 1068
R-GTAGGAACCAGCAAGAAGC
GRA5 EU918733.1 F-TCAACGCGTGACGTAGGG 132
R-TCCAGTCACCGCTGCTC
SAG1 AY217784.1 F-TCGGATCCCCCTCTTGTT 867
R-CGCGACACAAGCTGCGAT
SUS1 U77677.1 F-TCTCCTCTTTCGATGGCC 1131
R-GACGGCACCAAACATAGC
SAG3 JF312642.1 F-GAGCACGGACTGTTCGTCG 1035
R-GGCAGCCACATGCACAAGG
BAG1 XM_002365075.1 F-ATGGCGCCGTCAGCATCGC 687
R-CTTCACGCTGATTTGTTGCT
BSR4 XM_002369844.1 F-GATAATCTTCTTGAAGGAC 1038
R-GGCGGCCGCGCTAGAGGC
SRS8 XM_002371596.1 F-GAACAACTCGGCGAAGG 1077
R-AAGGGAACCGGCAAGAAGC
SRS9 AF465609.2 F-GACAGTCTGCATGAAGGA 1077
R-CAATGAAGCAACAACGAAC
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Most of the commercially available tests use T. gondii na-
tive antigens derived from the fast growing tachyzoites
which may result in variations in accuracy of detection.
Recombinant antigens have been suggested as diagnostic
reagents but their reliability may need extensive experi-
mental validation [17,18]. Further, T. gondii remains dor-
mant as bradyzoites in immune competent individuals,
which can convert to tachyzoites when the host immune
defense system is compromised, and tachyzoites and
bradyzoites do display different antigenic profiles [19].
Thus it is critical to select accurate antigens for diagnostic
and epidemiological purposes.
In this study, we investigated the level of anti-T. gondii
IgG and IgM in the sera of more than 800 Chinese indi-
viduals living in the southern and northern regions of
China, comparing crude antigens of RH (Type I) and
ME49 (Type II) strains and 12 recombinant antigens of
either Type I or Type II T. gondii. The purpose is to
compare the sensitivity and consistency in detection of
T. gondii specific antibodies in the same set of samples
with different antigens.
Methods
Study populations and serum samples
880 serum samples from clinically healthy individuals
were collected in Changchun, Daqing and Shanghai
areas in China from July 2006 to June 2012 as described
previously [20]. The sera were collected with the con-
sent of the volunteers. The study was carried out with
permission from the Ethical Committee of Institute of
Zoonosis, Jilin University, China.
Antigens
Soluble native parasite antigens: T. gondii tachyzoites of
RH and ME49 strains were cultivated in BHK (baby
hamster kidney) cell lines as described earlier [21].
Briefly parasites released from host cells were harvested,
washed in PBS and lysed by sonication. The insoluble
component such as cell debris was eliminated by centri-
fugation (12,000 rpm for 30 min) and the soluble pro-
teins, respectively termed RH-Ag and ME49-Ag were
collected and diluted to a final concentration of 1 mg/ml
in PBS for the serological test.
Recombinant antigens: To generate the recombinant
antigens, the coding sequences of T. gondii, which in-
cluding tachyzoite-specific (SAG1, SAG5A and SAG5D),
bradyzoite-specific (BAG1, BSR4 and SRS9) and com-
mon antigens (MIC6, SRS4, GRA5, SUS1, SAG3, and
SRS8) likely expressed in both tachyzoites and
bradyzoites were amplified by the Polymerase Chain Re-
action (PCR). Their accession numbers and primer se-
quences are listed in Table 1. Genomic DNA was
isolated from the tachyzoites of the T. gondii RH andME49 strains and was used as the template for PCR
amplification of the coding sequences. The PCR reaction
was carried out in a 25 μl reaction mixture containing
10 μM of each primer, 2.5 mM of each dNTP, 1.25 U of
Ex Taq DNA polymerase (TAKARA), 0.5 μg DNA tem-
plate, and 1 × Ex Taq buffer. The touchdown PCR was
performed on the PCR System (Applied Biosystems, CA,
USA) with a program of initial denaturation for 4 min at
94°C; 35 cycles of 94°C for 45 s, annealing for 45 s (ini-
tial temperature 61°C, then decreasing by 0.3°C/cycle),
and 72°C for 2 min; and a final extension at 72°C for 10
min. The PCR products were respectively cloned into
the plasmid pGEX-4T-1 (GE Healthsystems, Uppsala,
Sweden) and PET-28a (Qiagen, Düsseldorf, Germany) to
construct recombinant plasmids, which were subse-
quently confirmed by sequencing. The plasmids with
correct sequences were transformed into BL21 compe-
tent cells and the His-tag and GST-tag fusion proteins
were expressed and purified according to a standard
protocol as described [22]. They were respectively
named as RH-rAg, ME49-rAg and RH/ME49-rAg. The
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tion of 1 mg/ml in PBS for the serological test.
Serological assay
Indirect ELISA assays were performed to measure the
anti-T. gondii IgG level according to the standard proto-
col [23]. All reaction steps except coating and washing
were performed at 37°C. Briefly, Maxisor micro-ELISA
plates (Nalge Nunc International, IL, USA) were coated
with 50 μl per well of the T. gondii antigens (RH-Ag,
ME49-Ag and 12 recombinant antigens, respectively) in
a concentration of 5 μg/ml at 4°C overnight. The plates
were washed five times with PBS containing 0.05%
Tween 20 and blocked for 3–4 h at 37°C with 100 μl per
well of 0.5% BSA in PBS. After washing, 50 μl of each
serum sample, diluted at 1:50 was added to the well in
triplicates for 1 h. Alkaline phosphatase-labelled goat an-
tihuman IgG (Sigma, St. Louis, USA, 1:2000 dilution)
was added to the well after washing. Finally, 50 μl of
NPP [4-Nitrophenyl phosphate disodium salt hexahy-
drate] (Sigma, St. Louis, USA) and 9.7% diethanolamine
(pH 9.8) were used to detect antigen-antibody reactions.
The plates were finally read in a Biotek 93 micro-ELISA
auto-reader 808 at 405 nm. A human serum sample,
which was previously confirmed with negative reactivity
to T. gondii by the direct agglutination test was included
as a negative control in every plate. The GST protein was
used as control for the GST-tag fusion antigens. The cut-
off point of OD value for a positive sample was set to be
at least two times higher than that of the negative sample
at any dilution point as described previously [20].
To further confirm the ELISA data, all positive and 50
randomly selected negative sera were further tested by
the commercial T. gondii IgG/IgM Kits (Haitai Biological
Pharmaceuticals Co., Ltd, China) that can respectively
detect human IgG and IgM, and Western blot assays
using soluble extract of T. gondii. The procedure of the
commercial IgG/IgM kit was performed according to
the manufacturer’s instruction [24]. For the purpose of
Western blot assays, the parasite-derived soluble pro-
teins were separated on a 12% SDS-PAGE gel and trans-
ferred onto nitrocellulose membranes (Bio-Rad, CA,
USA). The membrane was cut into strips and incubated
with the positive and negative sera (at 1:50 dilution)
identified in the ELISA assays. Meanwhile, a serum of an
individual previously confirmed with T. gondii infection
was used as a positive control. The membrane strips
were further incubated with an alkaline phosphatase-
conjugated goat anti-human IgG antibody (1:20000 dilu-
tions) after washing in TBST buffer (10 mM Tris, 150
mM NaCl, pH 8.0 and 0.05% Tween 20). Eventually, the
strips were incubated with BCIP/NBT substrate solution
to visualize the protein bands that were recognized by
the specific antibodies.Statistical analysis
The results were statistically analyzed using the SPSS
18.0 software package. Chi-square test was used to
analyze the anti-T. gondii IgG seroprevalence by using
twelve T. gondii antigens. The differences were consid-
ered to be statistically significant when the p value was
less than 0.05 [20].
Results and discussion
In this study, the prevalence of anti-T. gondii antibodies
(primarily IgG) in 880 individuals was detected using
tachyzoite-derived crude parasite antigens of RH (RH
-Ag, type I) and ME49 (ME49-Ag, Type II), and 12
recombinant antigens (Rec-Ag) of T. gondii. The preva-
lence of anti-T. gondii IgG in the study population
obtained with crude antigens was 12.2% and 11.3%, re-
spectively (Table 2). We have previously investigated
T. gondii prevalence in clinical healthy individuals with
crude antigens of the RH strain T. gondii, the results
obtained in this study was consistent with our previous
study [20]. However, among the 173 samples which were
positive, only 20 samples were positive by both RH-Ag
and ME49-Ag (Table 2 and Figure 1), suggesting strong
strain-specific immune-response in the population.
Though the data reflected the exposure of T. gondii in the
investigated population, the actual seroprevalence of infec-
tion may be under represented due to the fact that both
RH-Ag and ME49-Ag were generated from tachyzoites. It
is well known that T. gondii remains as the relatively qui-
escent bradyzoite stage in immuocompetent hosts, and
comparative studies indicated that bradyzoites and
tachyzoites do have different gene expression profiles,
which may result in differences in elicitation of host im-
mune responses [25]. However, due to technical difficul-
ties in obtaining enough bradyzoites, the currently
diagnostic antigens have all been obtained from the fast
growing tachyzoites.
To test the differences in seroprevalence with tachyzoite-
and bradyzoite-derived antigens, twelve recombinant
antigens including three tachyzoite-specific, three bradyzoite-
specific and six antigens likely expressed by both
tachyzoites and bradyzoites (Table 2). These antigens
have been previously proved to be immunogenic and fre-
quently recognized by human antibodies [26-28]. The
seroprevalence of specific IgG to the individual recombin-
ant antigens were around 10%, with one exception, the
positive rate (14.9%) of BAG1-GST was significantly
higher than that observed with other recombinant anti-
gens or even crude antigens (p < 0.05) (Table 2). Thus
immuno-recognition of BAG1 is likely more prominent
than other bradyzoite antigens during chronic infection.
BAG1 was a 30 kDa cytosolic protein which is only
expressed in the bradyzoites [29,30]. Immunological stud-
ies suggested that BAG1 was very immunogenic and could
Table 2 Positive serum number and prevalence of anti-T. gondii IgG detected with different antigens
Strain of T.
gondii
Antigen names Stage and location Number of samples (n = 880) with anti-T. gondii IgG and prevalence (%)
Independent positive rate Cross-positive rate Combined positive rate
Inter-strains
RH RH-Ag Tachyzoite crude antigens 107 (12.2%)
ME49 ME49-Ag Tachyzoite crude antigens 99 (11.3%)
SAG5D Tachyzoite, surface 87 (9.9%) 17.5%
SAG5A Tachyzoite surface 93 (10.6%)
RH-rAg MIC6 Microneme 96 (10.9%)
SRS4 Surface 98 (11.2%)
GRA5 Dense granule 91 (10.4%) 15.6%
SAG1 Tachyzoite surface 93 (10.6%)
ME49-rAg SUS1 Surface 93 (10.6%) 28.2%
SAG3 Surface 96 (10. 9%)
BAG1 Bradyzoite, cytoplasmic 131 (14.9%)
RH/ME49-rAg BSR4 Bradyzoite, surface 94 (10.7%) 19.2%
SRS8 Surface 104 (11.8%)
SRS9 Bradyzoite, surface 97 (11.0%)
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sponses upon infection in humans [31]. Thus it is not so
surprising to observe a most prominent recognition of
BAG1 by the sera compared to other tachyzoite- and
bradyzoite-derived antigens.
On further analysis of the serum samples which were
positive in the ELISA test, surprisingly it was found that
the samples did not all overlapped or consistently react
with the three kinds of antigen (Figure 1A). Among the
394 positive samples, 107 sera were positive with RH-Ag,
99 were positive with ME49-Ag and 248 were positive
with the recombinant antigens. 20 samples which
accounted for only 5.1% of all positive samples wereFigure 1 Number of positive sera in a clinically healthy population de
percentage (in bracket) of 394 sera with T. gondii-specific IgG detected by
B shows the numbers and percentage (in bracket) of the 208 positive sera
(RH-rAg, ME49-rAg, RH/ME49-rAg).detected by both RH-Ag and ME49-Ag. 20 samples,
5.1% of all positive sera, were detected by both RH-Ag
and the Rec-Ags, and 26 sera, 6.6% of all positive sam-
ples, were detected by both ME49-Ag and the Rec-Ags
(Figure 1A). Only 6 samples were positively detected in
reactions with all three kinds of antigen and accounted
for 1.5% of all positive samples. The reason that rAgs
were more sensitive than native antigens may be due to
the low concentration of the immunogenic components
in the crude antigens. During T. gondii infection, a
broad range of parasite antigens will be presented to
the host immune system, thus the detection sensitivity
using crude antigens will be affected by factors such astected with three kinds of antigen. A shows the numbers and
the crude antigens of RH, ME49 strain and recombinant antigens.
with T. gondii-specific IgG detected by the recombinant antigens
Table 3 The positive rates of samples detected with the






(n = 248) (n = 50,
randomly selected)
positive negative positive negative (Among
serum
samples)
n % n % n % n %
com-IgG Kit 211 85.1 37 14.9 1 2 49 98 P < 0.01
com-IgM Kit 108 43.5 140 56.5 0 0 50 100
WB-RH 178 71.7 70 28.3 1 2 49 98
WB-ME49 202 81.5 46 18.5 5 10 45 90 P < 0.05
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action, and strain-specific responses. Similar results
have been reported in previous studies [32,33].
Analysis of the ELISA results in the assays with re-
combinant antigens of RH and ME49 strains showed,
however, more overlapping between different strains
(Figure 1B and Table 2). Among the 248 positiveFigure 2 Western blot analysis of serum samples. A shows the exampl
proteins. B shows the example of the serum samples that recognized a do
M: pre-stained Protein Molecular Weight Marker.samples detected with the 12 recombinant antigens of
either RH-, ME49- or common (RH/ME49) type, 71
samples were positive in reactions with all three types of
antigen, which accounted for 28.6% of all positive sam-
ples, even though the detection rates with strain-specific
rAgs were higher. The data further supported the finding
that a combination of several immune-dominant anti-
gens will generate a higher diagnostic efficiency [32]. In
contrast, 6.9% of the positive sera samples were detected
by both RH-rAg and ME49-rAg, 11.3% were detected by
both RH-rAg and common RH/ME49-rAg, and 9.7%
were detected by both ME49-rAg and RH/ME49-rAg.
To determine the reliability of the ELISA results based
on recombinant antigens, the 284 positive sera were fur-
ther validated with two commercial Toxoplasma gondii
IgG/IgM Kits and Western blot assays. 85.1% and 43.5%
of the positive samples previously identified by the ELISA
assay were confirmed by the com-IgG and com-IgM kit,
respectively, whereas a 2% and 0% positive rate were
found in the selected negative serum samples (P < 0.01)
(Table 3). The data suggested, in one aspect, that halfes where the serum samples recognized multiple bands of T. gondii
minant T. gondii protein. NC: negative control; PC: positive control;
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at the sample time. In another aspect, a combination of
antigens with different parasite strains will be needed
to achieve a higher diagnostic efficiency and a broader
coverage. Western blot assays showed that 71.7% and
81.5% of the ELISA positive samples were found to be
immunoreactive with the native proteins of RH and
ME49 strain, respectively (Table 3), which further sup-
ported the ELISA data. Examples of Western blots were
shown in Figure 2 with variation in recognition of mul-
tiple bands (Figure 2A) and single bands (Figure 2B) by
the serum samples. These results, again, suggested that
the immune recognition of T. gondii antigens varied
among different individuals.
Conclusions
In this study, we compared the immunorecognition of
three kinds of T. gondii strain- and developmental
status-specific antigens with the same set of sera. Results
clearly showed that there were strikingly differences in
the recognition of these antigens among the samples.
The prevalence of anti-T. gondii IgG obtained with crude
native RH-Ag and ME49-Ag was similar, whereas the
prevalence obtained with recombinant antigens (rAgs)
was significantly higher than that of the crude antigens.
More importantly, the number of sera that cross-reacted
with the three kinds of antigen was low, accounting for
only 1.5% of the positive samples. Nevertheless the re-
combinant antigens had shown a significantly higher
consistency in detection of T. gondii-specific IgG in the
serum samples. Thus, the general prevalence of anti-T.
gondii IgG was likely much higher than previously
reported. The data further supported the conclusion that
there is more genetic diversity among the T. gondii iso-
lates in China [14-16], which argue for the necessity of
the establishment of a method that can detect most, if
not all, of the variant specific antibodies.
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